Prospective Evaluation of Pancreatic, Biliary, and Gastrointestinal Neoplasia by Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound are increasingly being used to manage complex disease of the bile duct, pancreas and cancer. Gastroenterology patients at the Los Angeles County Hospital presents a unique and diverse patient population. Our aim is to study the biochemical, radiographic, and clinical predictors of bile duct stones. Exploratory aims include the study of the management of cholangitis, bile leaks, GI cancer diagnosis and management, and the management of pancreaticobiliary problems in the underserved. All patients managed by EUS or ERCP at the LA County \& USC University Hospitals will be enrolled in the databaseThe timing, clinical presentation, and objective details of patient presentation are recorded prospectively. Additionally the results of the subsequent ERCP and EUS procedures. Subsequent, clinical course and pathology will also be recorded.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• All patients undergoing EUS or ERCP at LAC, UH, and Norris Cancer Hospitals as standard of clinical care will be enrolled.

Locations
United States
California
Los Angeles County Hospital
RECRUITING
Los Angeles
Contact Information
Primary
James Buxbaum, MD
jbuxbaum@usc.edu
3234096939
Backup
Maria Trujillo
mit@usc.edu
3234096939
Time Frame
Start Date: 2010-09
Estimated Completion Date: 2025-12
Participants
Target number of participants: 2500
Treatments
ERCP/EUS
All patients who undergo ERCP and EUS for clinical indications will undergo a detailed prospective assessment of clinical course.
Sponsors
Leads: University of Southern California

This content was sourced from clinicaltrials.gov